Christopher R. Lucas

1.0k total citations
13 papers, 750 citations indexed

About

Christopher R. Lucas is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Christopher R. Lucas has authored 13 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Biomedical Engineering and 3 papers in Immunology. Recurrent topics in Christopher R. Lucas's work include Advanced biosensing and bioanalysis techniques (7 papers), RNA Interference and Gene Delivery (6 papers) and Diabetes and associated disorders (2 papers). Christopher R. Lucas is often cited by papers focused on Advanced biosensing and bioanalysis techniques (7 papers), RNA Interference and Gene Delivery (6 papers) and Diabetes and associated disorders (2 papers). Christopher R. Lucas collaborates with scholars based in United States and Ireland. Christopher R. Lucas's co-authors include Carlos E. Castro, Randy A. Patton, Steven K. Clinton, Amir Mortazavi, Patrick D. Halley, Kenneth M. Riedl, Emily M. McWilliams, Matthew J. Webber, Cömert Kural and John C. Byrd and has published in prestigious journals such as Advanced Materials, ACS Nano and The Journal of Immunology.

In The Last Decade

Christopher R. Lucas

12 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher R. Lucas United States 9 633 203 80 61 43 13 750
Jun Fan China 16 336 0.5× 85 0.4× 72 0.9× 17 0.3× 14 0.3× 43 724
Su Cheong Yeom South Korea 13 343 0.5× 180 0.9× 50 0.6× 8 0.1× 22 0.5× 33 669
Liqun Zhao China 12 439 0.7× 59 0.3× 79 1.0× 12 0.2× 56 1.3× 24 741
Mohammad Shafiei Iran 13 242 0.4× 145 0.7× 19 0.2× 18 0.3× 114 2.7× 48 533
Kirsty M. McLaughlin United Kingdom 13 476 0.8× 109 0.5× 87 1.1× 45 0.7× 18 0.4× 16 731
Lijuan Li China 12 307 0.5× 91 0.4× 73 0.9× 15 0.2× 41 1.0× 23 479
Albert Green United States 13 338 0.5× 79 0.4× 51 0.6× 86 1.4× 6 0.1× 24 650
Sei Yonezawa Japan 13 463 0.7× 243 1.2× 78 1.0× 7 0.1× 29 0.7× 29 807
Edward Cedrone United States 15 336 0.5× 50 0.2× 111 1.4× 27 0.4× 37 0.9× 37 551

Countries citing papers authored by Christopher R. Lucas

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Lucas more than expected).

Fields of papers citing papers by Christopher R. Lucas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Lucas. The network helps show where Christopher R. Lucas may publish in the future.

Co-authorship network of co-authors of Christopher R. Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Lucas. A scholar is included among the top collaborators of Christopher R. Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Lucas. Christopher R. Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lucas, Christopher R., Patrick D. Halley, Bonnie K. Harrington, et al.. (2022). DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo. Small. 18(26). e2108063–e2108063. 61 indexed citations
2.
Lucas, Christopher R., et al.. (2022). Multiplexed Detection of Molecular Interactions with DNA Origami Engineered Cells in 3D Collagen Matrices. ACS Applied Materials & Interfaces. 14(50). 55307–55319. 4 indexed citations
3.
McWilliams, Emily M., Christopher R. Lucas, Timothy F. Chen, et al.. (2019). Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib. Blood Advances. 3(3). 447–460. 39 indexed citations
4.
Lucas, Christopher R., et al.. (2018). Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention. Molecular Nutrition & Food Research. 62(18). e1800079–e1800079. 118 indexed citations
5.
Mollica, Molly Y., et al.. (2017). Engineering Cell Surface Function with DNA Origami. Advanced Materials. 29(46). 116 indexed citations
6.
Mollica, Molly Y., et al.. (2017). Cell‐Membrane Engineering: Engineering Cell Surface Function with DNA Origami (Adv. Mater. 46/2017). Advanced Materials. 29(46). 2 indexed citations
7.
Telu, Kelly H., Christopher R. Lucas, Jennifer M. Thomas‐Ahner, et al.. (2017). The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer. Journal of Proteomics. 156. 94–103. 50 indexed citations
8.
Luo, Yi, et al.. (2016). Probing Nucleosome Stability with a DNA Origami Nanocaliper. ACS Nano. 10(7). 7073–7084. 79 indexed citations
9.
Halley, Patrick D., Christopher R. Lucas, Emily M. McWilliams, et al.. (2016). DNA Origami: Daunorubicin‐Loaded DNA Origami Nanostructures Circumvent Drug‐Resistance Mechanisms in a Leukemia Model (Small 3/2016). Small. 12(3). 307–307. 7 indexed citations
10.
Kearney, Cathal J., Christopher R. Lucas, Fergal J. O’Brien, & Carlos E. Castro. (2016). DNA Origami: Folded DNA‐Nanodevices That Can Direct and Interpret Cell Behavior. Advanced Materials. 28(27). 5509–5524. 53 indexed citations
11.
Halley, Patrick D., Christopher R. Lucas, Emily M. McWilliams, et al.. (2015). Daunorubicin‐Loaded DNA Origami Nanostructures Circumvent Drug‐Resistance Mechanisms in a Leukemia Model. Small. 12(3). 308–320. 184 indexed citations
12.
Lucas, Christopher R., Jaclyn W. McAlees, Sumeena Bhatia, et al.. (2012). Prohibitins and the Cytoplasmic Domain of CD86 Cooperate To Mediate CD86 Signaling in B Lymphocytes. The Journal of Immunology. 190(2). 723–736. 37 indexed citations
13.
Lucas, Christopher R., et al.. (2012). Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes (42.5). The Journal of Immunology. 188(1_Supplement). 42.5–42.5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Fan Breakdown of academic impact, for papers by Su Cheong Yeom Breakdown of academic impact, for papers by Liqun Zhao Breakdown of academic impact, for papers by Mohammad Shafiei Breakdown of academic impact, for papers by Kirsty M. McLaughlin Breakdown of academic impact, for papers by Lijuan Li Breakdown of academic impact, for papers by Albert Green Breakdown of academic impact, for papers by Sei Yonezawa Breakdown of academic impact, for papers by Edward Cedrone
Rankless by CCL
2026